Content area

Abstract

Cattle marketed through auction market systems and/or that remain unvaccinated are considered higher risk for BRD, but impacts on host response remain unclear. We sought to identify specific genomic patterns of beef calves vaccinated against BRD viruses or not and commercially marketed or directly transported in a split-plot randomized controlled trial. Forty-one calves who remained clinically healthy from birth through backgrounding were selected (randomly stratified) from a larger cohort of cattle (n = 81). Treatment groups included VAX/DIRECT (n = 12), VAX/AUCTION (n = 11), NOVAX/DIRECT (n = 7), and NOVAX/AUCTION (n = 11). Blood RNA was acquired across five time points, sequenced, and bioinformatically processed via HISAT2 and StringTie2. Significant transcriptional changes (FDR < 0.05) were observed at backgrounding entry (T5) in NOVAX/AUCTION cattle exhibiting 2809 uniquely differentially expressed genes and relative activation of immune, inflammatory, and metabolic pathways with upregulation of interferon-stimulated genes (e.g., IFIT3, MX2, and TRIM25) and downregulation of specialized proresolving mediator (SPM) enzymes (ALOX5 and ALOX15). VAX/AUCTION cattle exhibited modulated immune activation and preserved expression of SPM-associated genes when compared to NOVAX/AUCTION cattle. Both marketing route and vaccination shape the molecular immune landscape during high-stress transitions, with preweaning vaccination potentially modulating this response. This study provides mechanistic insight into how management practices influence immunological resilience and highlights the value of integrating transcriptomics into BRD risk mitigation.

Details

1009240
Business indexing term
Title
Proinflammatory Cytokines, Type I Interferons, and Specialized Proresolving Mediators Hallmark the Influence of Vaccination and Marketing on Backgrounded Beef Cattle
Author
McAllister, Hudson R 1   VIAFID ORCID Logo  ; Capik, Sarah F 2   VIAFID ORCID Logo  ; Harvey, Kelsey M 3 ; Ramirez, Bradly I 1 ; Valeris-Chacin Robert J. 1 ; Woolums, Amelia R 4 ; Karisch, Brandi B 5   VIAFID ORCID Logo  ; Morley, Paul S 1   VIAFID ORCID Logo  ; Scott, Matthew A 1   VIAFID ORCID Logo 

 Veterinary Education, Research, and Outreach Program, Texas A&M University, Canyon, TX 79015, USA 
 Tumbleweed Veterinary Services, PLLC, Amarillo, TX 79118, USA, Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA 
 Prairie Research Unit, Mississippi State University, Prairie, MS 39756, USA 
 Department of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS 39762, USA 
 Department of Animal and Dairy Sciences, Mississippi State University, Mississippi State, MS 39762, USA 
Publication title
Volume
12
Issue
9
First page
834
Number of pages
18
Publication year
2025
Publication date
2025
Publisher
MDPI AG
Place of publication
Basel
Country of publication
Switzerland
Publication subject
e-ISSN
23067381
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-08-30
Milestone dates
2025-07-01 (Received); 2025-08-27 (Accepted)
Publication history
 
 
   First posting date
30 Aug 2025
ProQuest document ID
3254655228
Document URL
https://www.proquest.com/scholarly-journals/proinflammatory-cytokines-type-i-interferons/docview/3254655228/se-2?accountid=208611
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-09-26
Database
2 databases
  • ProQuest One Academic
  • ProQuest One Academic